We have found that endothelial cells adhere much more strongly than fibroblasts to domains of tenascin and fibronectin. Endothelial cells adhered weakly, without spreading, to bacterial expression proteins corresponding to the tenth fibronectin type III (FN-III) domain of fibronectin, which contains the RGD. A larger fibronectin protein, containing this domain and the three amino-terminal ‘synergy’ domains gave strong adhesion and spreading. Two widely separated domains of tenascin gave adhesion. The third FN-III domain, TNfn3, which contains an RGD sequence in human and chicken tenascin, gave very strong adhesion and spreading of endothelial cells when tested as an isolated domain. Larger segments containing TNfn3 and the adjacent TNfn2 gave weaker adhesion, probably because the RGD sequence is partially blocked. Adhesion to this domain required divalent cations, was exquisitely sensitive to soluble GRGDSP peptide, and was blocked by antisera to the integrin αvβ3. The second tenascin adhesion domain was the fibrinogen-like C-terminal knob, TNfbg. Cells adhered to but did not spread on this domain. This adhesion required divalent cations and was also sensitive to GRGDSP peptide, so it may be mediated by an integrin receptor.

We have explored a range of conditions for preparing the adhesion substratum, and our results may resolve the controversy over whether tenascin can act as a substratum adhesion molecule. When coated for short times (1-2 hours) on plastic, tenascin had no adhesion activity, in contrast to fibronectin and the expression proteins, which gave strong adhesion under these conditions. When coated for longer times (12-24 hours) on plastic, the tenascin substratum supported good adhesion, but not spreading, of endothelial cells. Tenascin coated on nitrocellulose gave substantially stronger adhesion than on plastic, but still required long coating times for maximal activity. Adhesion of endothelial cells to native TN was inhibited by GRDGSP peptide. The cell adhesion activity demonstrates the presence on endothelial cells of tenascin receptors, which may play a supportive role in angiogenesis, in the structure of blood vessels, or in binding tenascin to the cell surface to elicit or enhance a signalling function.

Tenascin (TN) is a large ECM protein prominent in restricted embryonic tissues, healing wounds and tumors (Erickson and Bourdon, 1989). Six elongated subunits are linked by disulfides into a 2,000 kDa molecule called the hexabrachion. Each arm of the hexabrachion is a tenascin subunit, and comprises 14 domains homologous to epidermal growth factor (EGF), 8-15 FN-III domains, and a fibrinogen-like domain (Fig. 1). The third FN-III domain (TNfn3) in human TN has an RGD on the loop connecting beta strands F and G (Leahy et al., 1992), which is the same location as the RGD in the fibronectin (FN) domain FNfn10 (Main et al., 1992). There has been considerable interest in testing TN for cell adhesion activity, with controversial results reported by several laboratories (reviewed by Erickson and Bourdon, 1989).

Fig. 1.

Diagram of the domain structure of the TN subunit, and the expression proteins used in the present study. In addition to the TN proteins, two expression proteins for FN used in this study are indicated. (From Aukhil et al., 1993.)

Fig. 1.

Diagram of the domain structure of the TN subunit, and the expression proteins used in the present study. In addition to the TN proteins, two expression proteins for FN used in this study are indicated. (From Aukhil et al., 1993.)

More recently, attention has focused on possible antiadhesion activities of TN. Chiquet-Ehrismann et al. (1988) reported that TN could inhibit adhesion of cells to a fibronectin (FN) substratum. Lightner and Erickson (1990) confirmed these observations and concluded that the mechanism was steric blocking of the substratum. The large hexabrachion molecules bound to the plastic, straddling the fibronectin molecules and efficiently covering up their cell adhesion sites.

Anti-adhesion mechanisms have been attributed to two specific domains of TN. Murphy-Ulrich et al. (1991) reported that the alternatively spliced segment of TN (TNfnA-D in Fig. 1) caused a loss of focal contacts when added as a soluble protein to well-spread endothelial cells. Chiquet et al. (1991) reported that a proteolytic fragment comprising the last three FN-III repeats and the fibrinogen domain (TNfn6-8 plus TNfbg) inhibited spreading of fibroblasts on FN. Prieto et al. (1992) reported an anti-adhesion effect of a fusion protein corresponding approximately to TNfn7-8. Inhibition of adhesion and spreading was observed when this fusion protein was incorporated as a mixed substratum with FN, and also when pre-incubated with cells. These last two reports both indicate an anti-adhesion activity in TNfn7-8.

To provide tools for extended studies of TN, we have produced a library of bacterial and mammalian expression proteins that map the entire hexabrachion arm in defined segments (Aukhil et al., 1993; and Fig. 1). Each of the proteins corresponds to precisely defined boundaries of the FN-III domains and contains no fusion protein. The expression proteins are all soluble as monomeric molecules, and each has been highly purified. Of course these bacterial expression proteins are not glycosylated, but the biochemical analysis suggests that they are all correctly folded and otherwise identical to the domains in native TN (Aukhil et al., 1993). The set of bacterial proteins is complemented by mammalian expression proteins HxB.L, HxB.S and HxB.egf, corresponding to the large and small splice variants of human tenascin, and to a protein truncated at the end of the EGF segments. These three proteins are secreted by transfected BHK cells and assembled into normal hexabrachion molecules (Aukhil et al., 1993). Finally, we have produced two bacterial expression proteins for FN domains.

Of particular interest is the domain TNfn3, which has an RGD sequence in human and chicken TN, and whose structure has recently been solved to atomic resolution (Leahy et al., 1992). In our initial studies we found that fibroblasts did not adhere to TNfn3 or to larger segments containing it. However, Prieto et al. (1992) demonstrated adhesion of fibroblasts and other cells to fusion proteins containing TNfn3, using an assay that was perhaps more sensitive than ours.

A key observation leading to our present analysis was that endothelial cells adhere very strongly to TNfn3. As well, endothelial cells adhere much more strongly than fibroblasts to FNfn10, the RGD-containing domain from FN. Because endothelial cells exhibited the strongest adhesion to several proteins, and because TN is frequently associated with blood vessels (Erickson and Bourdon, 1989), we explored in detail adhesion of endothelial cells to domains of TN and FN, and compared them to several other cell lines that have weaker or no adhesion. Finally, we have new experimental work that addresses the controversy over whether intact TN can act as a cell adhesion substratum. The adhesion activity depends on the nature of the substratum (plastic vs nitrocellulose) and the length of time the TN is incubated on the substratum.

Cells and reagents

Non-transformed fetal bovine aortic endothelial cells (AG7680), and a transformed line derived from them (GM7373) (Grinspan et al., 1983; Maier et al., 1990) were obtained from Coriell Institute for Medical Research, Camden, NJ. Endothelial cells from mouse brain, heart and thorax were provided by Dr Robert Auerbach, Department of Zoology, University of Wisconsin, Madison. Cells were cultured in DMEM-H (Dulbecco’s Modified Eagle’s Medium, high glucose) with 10% fetal calf serum. NRK cells were obtained from the ATCC, and the hamster fibroblasts NIL.8M were obtained from Dr Richard Hynes, MIT. Anti-αvβ3and anti-α5β1antisera were purchased from Telios Pharmaceuticals, Inc., San Diego, CA. Native FN was purified from human plasma by gelatin-agarose affinity chromatography, and native TN was purified from conditioned medium of U-251 MG glioma cells by gel filtration and anion exchange chromatography (Aukhil et al., 1990).

Bacterial expression proteins for defined domains of TN and FN were produced and purified as described by Aukhil et al. (1993). Tenascin and the TNfn3 domain were iodinated by the Chloramine T method (Greenwood et al., 1963) to a specific activity of 0.3-1 mCi per μg of protein. The integrity of the labeled protein was determined by SDS-PAGE followed by autoradiography.

Cell adhesion assay

The assay was carried out as described by Lightner and Erickson (1990) and Aukhil et al. (1993). Falcon 3912 microtitre plates, which are 96-well polyvinylchloride plastic not treated for tissue culture, were used for quantitative assays. For experiments shown in Figs 2-8, substrata were coated with protein by adding 100 μl protein solution in phosphate buffered saline (PBS) at 37°C for 60 min. Wells were emptied, washed twice with PBS, and free sites on plastic were blocked by adding 1 mg/ml heat-denatured BSA for 1 hour, followed by a PBS wash. (For the experiments in Figs 9-10 the substratum proteins were coated in 20 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM CaCl2, 1 mM MgCl2 at the temperatures and times indicted, and then blocked with 5% nonfat dried milk. Also in these experiments, plastic substrata were compared with plastic over-coated with nitrocellulose, prepared as follows: 20 cm2 nitrocellulose paper (Bio-Rad) was dissolved in 50 ml of methanol, 20 μl of nitrocellulose solution was added to each well and dried under the laminar-flow hood.) Each well was loaded with 100 μl PBS (sometimes containing an inhibitor such as RGD peptide) and 35,000 to 50,000 cells in 100 μl DMEM medium. Prior to this assay the cells had been removed from their substratum by mild treatment with trypsin EDTA. The plates were incubated for 60 min at 37°C in an atmosphere of 5% CO2, unbound cells were removed by gentle pipetting, wells were washed twice with PBS and cells were fixed with 3% paraformaldehyde.

Fig. 2.

Attachment and spreading of endothelial GM7373 cells on substrata coated with recombinant FN or TN fragments. For these microscope examinations, Nunc Lab-Tek polystyrene chamber slides were coated with native FN (5 μg/ml), FNfn10 (10 μg/ml), FNfn7-10 (5 μg/ml), native TN (purified from U-251 MG cell cultures, 25 μg/ml), TNfn3 (5 μg/ml), TNfn1-5 (10 μg/ml), TNfnALL (10 μg/ml), TNfn1-8 (10 μg/ml), and TNfbg (25 μg/ml). GM7373 endothelial cells were harvested with trypsin-EDTA and allowed to attach and spread on the substratum for 1 hour before fixation and photography. The fields shown here were selected to show a large number of cells of representative morphology, and do not always reflect the number of cells bound, e.g. TNfnALL gave the weakest adhesion in the quantitative assay. Quantitation of adhesion is given in Fig. 3. Bar, 100 μm.

Fig. 2.

Attachment and spreading of endothelial GM7373 cells on substrata coated with recombinant FN or TN fragments. For these microscope examinations, Nunc Lab-Tek polystyrene chamber slides were coated with native FN (5 μg/ml), FNfn10 (10 μg/ml), FNfn7-10 (5 μg/ml), native TN (purified from U-251 MG cell cultures, 25 μg/ml), TNfn3 (5 μg/ml), TNfn1-5 (10 μg/ml), TNfnALL (10 μg/ml), TNfn1-8 (10 μg/ml), and TNfbg (25 μg/ml). GM7373 endothelial cells were harvested with trypsin-EDTA and allowed to attach and spread on the substratum for 1 hour before fixation and photography. The fields shown here were selected to show a large number of cells of representative morphology, and do not always reflect the number of cells bound, e.g. TNfnALL gave the weakest adhesion in the quantitative assay. Quantitation of adhesion is given in Fig. 3. Bar, 100 μm.

Attached cells were quantitated by staining with 1% Toluidine blue and lysing the cells with 2% SDS. The intensity of the color was measured at 595 nm. Readings in wells precoated with BSA (typically A595 ∼0.04) were considered as blank and subtracted from each value. Three duplicate wells were averaged for each point tested. The standard deviation of the three points was typically about 10% of the mean. Although this staining procedure does not permit an easy determination of the fraction of cells bound, we have previously determined (Lotz et al., 1989) that cell binding is saturated at 10 μg/ml FN, with >80% of the cells bound. The A595 corresponding to this saturated binding of cells to FN varied from 0.5 to 0.6 in most experiments, so A595 values of 0.3 or 0.1 indicate 50% and 20% of added cells bound.

Endothelial cell adhesion to recombinant TN and fibronectin domains

We tested the cell adhesion activity of all 12 of our bacterial expression proteins and the three mammalian TN constructs, as well as purified native TN and fibronectin. Most of our work used the transformed endothelial cell line GM7373, but identical results were obtained with each of the endothelial cell lines tested. Table 1 summarizes the adhesion results for the GM7373 cells, their untransformed parent line AG7860, and three other cell types. The adhesion responses fell into three distinctly different categories: (1) adhesion and spreading; (2) adhesion but no spreading (cells remain round); and (3) no adhesion (Fig. 2 and Table 1).

Table 1.

Cell adhesion to TN and FN expression proteins

Cell adhesion to TN and FN expression proteins
Cell adhesion to TN and FN expression proteins

An important preliminary discovery in these experiments was that endothelial cells adhere much more avidly than other cell types tested. This was particularly evident in adhesion to the single FN-III domains FNfn10 and TNfn3. All endothelial cells tested adhered to these domains, whereas fibroblasts did not. It is well established from previous studies that fibroblasts adhere and spread on FNfn7-10, but adhere very weakly or not at all to the single domain FNfn10 (Kimizuka et al., 1991; Aota et al., 1991; Aukhil et al., 1993). In addition to the two lines of fetal bovine aortic endothelial cells listed in Table 1, endothelial cell lines 14077-(P9) from mouse heart, 1841-(P9) from mouse brain, and 1-C4 from mouse thoracic duct, all provided by Dr R. Auerbach, University of Wisconsin, attached and spread on TNfn3. All of these endothelial cells also attached but remained rounded on TNfbg.

The only TN expression proteins that promoted cell adhesion were the domains TNfn3 (and larger segments that contain it) and TNfbg. No adhesion of any cell type was observed to TNfnA-D (the alternatively spliced segment), to TNfn6-8 (the last three FN-III domains), or to the mammalian expression protein HxB.egf, which comprises the central knob and the 14 EGF domains. Remarkably, preparations of native tenascin were completely negative for cell attachment in this assay condition (native TN in Fig. 2). Adhesion activity of native TN was later revealed by coating the protein on nitrocellulose or plastic for much longer times than the 60 min used for our routine assays (Figs 9-10).

Endothelial cell adhesion to TNfn3 is partially blocked by adjacent TNfn2 and is inhibited by RGD peptides and by antiserum to αvγ3

Fig. 3 shows the concentration dependence of adhesion to TNfn3 and to larger segments containing this domain. The single domain TNfn3 had the highest activity, and there was a clear trend toward reduced adhesion as more domains were added. The larger segments showed progressively less adhesion at a given coating concentration (e.g. 1-2 μg/ml), and the maximal adhesion obtained at any concentration was also reduced. Adhesion to the larger segments actually fell off at higher concentrations. This is seen in Fig. 3 for TNfn1-5, and was also observed for TNfn1-8 and TNfn-ALL, which gave reduced adhesion at 20 μg/ml and no adhesion at all when coated at 100 μg/ml (data not shown). The reduced adhesion activity of the larger fragments may be due to the increased steric blocking by the non-adhesive domains.

Fig. 3.

Attachment of GM7373 cells to TNfn3 and to three larger expression proteins containing this domain. The concentration of the protein used to coat the plastic substratum is shown on the abscissa. Results are the mean of triplicate observations in an experiment. Similar results were obtained when the experiment was repeated twice. BSA served as a negative control, and it’s value (A595 0.035) has been subtracted from all points.

Fig. 3.

Attachment of GM7373 cells to TNfn3 and to three larger expression proteins containing this domain. The concentration of the protein used to coat the plastic substratum is shown on the abscissa. Results are the mean of triplicate observations in an experiment. Similar results were obtained when the experiment was repeated twice. BSA served as a negative control, and it’s value (A595 0.035) has been subtracted from all points.

A second and very striking aspect of reduced adhesion was that the cells avidly spread on TNfn3, whereas on the larger domains they remained rounded (Fig. 2). Substrata giving the rounded phenotype did so at all coating concentrations, i.e. there was no indication that cell spreading could be obtained at higher substratum densities. It seems that TNfn3 has a very strong adhesion activity, sufficient to promote complete cell spreading, when presented on the substratum as an isolated domain, but this activity is severely reduced when the domain is incorporated into a larger segment. The explanation for this aspect of reduced adhesion was suggested by the X-ray crystal structure of Tnfn3.

The crystal structure showed that the RGD sequence in TNfn3 is on a tight beta turn, exposed on the surface of the domain (Leahy et al., 1992). Although the RGD sequence is toward the C terminus of the linear sequence, in the 3D structure it is seen to be very close to the N terminus. This suggested that the adjacent domain TNfn2 might partially block the RGD. To test this hypothesis we synthesized the segments TNfn1-3 and TNfn3-5 (Fig. 1). As seen in Figs 4 and 5, the adhesive activity of these segments is consistent with this prediction. Cells attached and spread on TNfn3 and TNfn3-5, both of which have the RGD exposed at the N terminus. Cell attachment to TNfn1-3 required higher substratum concentrations, and the cells remain rounded. The adhesion activity of TNfn1-3 was almost identical to that of TNfn1-5.

Fig. 4.

Attachment and spreading of GM7373 cells on TNfn3, TNfn1-3 and TNfn3-5 substrata. Cells attach and spread on TNfn3 and TNfn3-5 (coated at 5 μg/ml), in which the N terminus of TNfn3 is exposed, whereas they remain rounded on TNfn1-3 (coated at 10 μg/ml), in which the N terminus of TNfn3 (and the RGD sequence) is partially blocked by the adjacent TNfn2 (Leahy et al., 1992). Bar, 100 μm.

Fig. 4.

Attachment and spreading of GM7373 cells on TNfn3, TNfn1-3 and TNfn3-5 substrata. Cells attach and spread on TNfn3 and TNfn3-5 (coated at 5 μg/ml), in which the N terminus of TNfn3 is exposed, whereas they remain rounded on TNfn1-3 (coated at 10 μg/ml), in which the N terminus of TNfn3 (and the RGD sequence) is partially blocked by the adjacent TNfn2 (Leahy et al., 1992). Bar, 100 μm.

Fig. 5.

Quantitative assay of adhesion to TNfn3, TNfn1-3 and TNfn3-5, as a function of substratum-coating concentration.

Fig. 5.

Quantitative assay of adhesion to TNfn3, TNfn1-3 and TNfn3-5, as a function of substratum-coating concentration.

Since TNfn3 (from human and chicken) contains an RGD sequence, we tested whether RGD peptides would inhibit adhesion. Fig. 6 shows that adhesion to TNfn3 and to larger segments containing it is extremely sensitive to soluble RGD peptide. Adhesion to TNfn3 and TNfn3-5, on which cells spread, was inhibited 70% by 2.5 μg/ml of soluble GRGDSP. Adhesion to TNfn1-3 and to FNfn10 was inhibited at GRGDSP concentrations as low as 0.2-0.5 μg/ml. The control peptide GRGESP had no effect at 25 μg/ml. Adhesion to these domains is thus much more sensitive to soluble RGD peptides than is adhesion to intact fibronectin, which requires 350-1,000 μg/ml for ∼70% inhibition (Pierschbacher and Ruoslahti, 1984, and our unpublished data), or to vitronectin, which is inhibited by 35-100 μg/ml RGD (Pierschbacher and Ruoslahti, 1987).

Fig. 6.

Soluble GRGDSP inhibits cell attachment to the RGD-containing domains from TN and FN. The substratum-coating concentrations were 1 μg/ml for TNfn3; 2.5 μg/ml for TNfn3-5; 20 μg/ml for TNfn1-3; and 5 μg/ml for FNfn10.

Fig. 6.

Soluble GRGDSP inhibits cell attachment to the RGD-containing domains from TN and FN. The substratum-coating concentrations were 1 μg/ml for TNfn3; 2.5 μg/ml for TNfn3-5; 20 μg/ml for TNfn1-3; and 5 μg/ml for FNfn10.

The sensitivity to RGD peptides strongly suggests that the adhesion is mediated by an integrin receptor. An inte-grin interaction was also suggested by the cation requirement for adhesion: EDTA or EGTA (2.5 mM) completely abolished cell attachment to TNfn3, TNfn1-5 and FNfn10 (data not shown).

To confirm the involvement of integrins and to identify the specific molecules, we obtained polyclonal antisera against αvβ3and α5β1integrins, which block the activity of the specific integrin (see Massia and Hubbell, 1991, for a previous use of these antisera). Cell attachment to TNfn3 was inhibited by anti-αvβ3antiserum (Fig. 7). This antiserum also inhibited cell attachment to TNfn1-5 and to FNfn10. Anti-α5β1antiserum gave no inhibition on any substrata. These results suggest that endothelial cell adhesion to TNfn3 and to FNfn10 is mediated by the integrin αvβ3.

Fig. 7.

Effects of integrin-specific antisera on GM7373 cell attachment to TNfn3 (open circles) or FNfn10 (filled circles). The coating concentrations of TNfn3 and FNfn10 were 1 and 3.6 μg/ml, respectively. (A) shows the effect of different dilutions of anti-αvβ3, and (B) shows anti-α5β1.

Fig. 7.

Effects of integrin-specific antisera on GM7373 cell attachment to TNfn3 (open circles) or FNfn10 (filled circles). The coating concentrations of TNfn3 and FNfn10 were 1 and 3.6 μg/ml, respectively. (A) shows the effect of different dilutions of anti-αvβ3, and (B) shows anti-α5β1.

Endothelial cells adhere to TNfbg

Only one other TN domain, TNfbg, showed cell adhesion activity for endothelial cells. In a previous study we observed that fibroblasts attached to TNfbg, and that adhesion was mediated by a cell surface proteoglycan, not an integrin (Aukhil et al., 1993). Thus fibroblast cell attachment was inhibited by treating the substratum with heparin (which binds to TNfbg), or by treating the cells with heparinase (which cleaves cell surface heparan sulfate) or with chlorate ions (which inhibit sulfation of proteoglycans). We expected the adhesion of endothelial cells to TNfbg also to be mediated by proteoglycans. However, several experiments (data not shown) suggest that endothelial cell adhesion to TNfbg is mediated by integrins, with little or no contribution from proteoglycans. (1) Adhesion was completely eliminated by adding 2.5 mM EDTA or EGTA to the medium. These chelators had no effect on fibroblast adhesion to TNfbg, but are known to inhibit integrin-mediated adhesion (Hynes, 1992). (2) Adhesion of endothelial cells to TNfbg was not inhibited by heparin, or by treating the cell cultures with chlorate. (3) Adhesion was inhibited by the peptide GRGDSP (Fig. 8) at peptide concentrations of 25-50 μg/ml, similar to the concentration that inhibits cell adhesion to vitronectin. Endothelial cell adhesion to TNfbg was not inhibited by the antisera to either the αvβ3or the α5β1integrins.

Fig. 8.

Inhibition of GM7373 cell adhesion to TNfbg by GRGDSP peptide. The substratum coating concentration was 20 μg/ml.

Fig. 8.

Inhibition of GM7373 cell adhesion to TNfbg by GRGDSP peptide. The substratum coating concentration was 20 μg/ml.

A search for anti-adhesion domains

Since two domains of TN gave adhesion of endothelial cells when tested as isolated domains, we wanted to address the question: why do endothelial cells not adhere to native TN? One possibility was that an anti-adhesion domain might overwhelm the adhesion activity. Our interest focused on two segments: first, the segment TNfnA-D, which we have found to provoke dismantling of focal adhesions when added to endothelial cells spread on fibronectin (Murphy-Ullrich et al., 1991); second, the segment TNfn6-8, which has been identified in two studies as inhibiting the adhesion and/or spreading of fibroblasts on FN (Chiquet et al., 1991; Prieto et al., 1992).

We first addressed this question by testing our mammalian expression proteins, HxB.L and HxB.S, corresponding to the two splice variants of native TN. Each of these is assembled by the cells and secreted as intact hexabrachions. Since HxB.S is missing the alternatively spliced segment (TNfnA-D), cells would be expected to adhere to it if this segment were responsible for a dominant anti-adhesion effect. However, we found that endothelial cells did not adhere to HxB.L, HxB.S (or to HxB.egf, a truncated hexabrachion containing only the EGF domains) at any substratum coating concentrations tested, up to 100 μg/ml. (Note that these experiments were all done by coating the proteins for 60 min on plastic; cf. Figs 9-10, below, for conditions giving positive adhesion to native TN.) Thus the alternatively spliced segment does not seem to be responsible for the lack of cell adhesion to native TN.

We next made an equimolar mixture of bacterial expression proteins TNfn1-5, TNfnA-D, TNfn6-8 and TNfbg, and the mammalian protein HxB.egf. This mixture should be equivalent to a complete TN subunit. This mixture was used to coat plastic at concentrations of 20, 100 and 200 nM (total protein concentration 5-50 μg/ml) and tested for cell adhesion. GM7373 cells adhered to this substratum at all three concentrations, the cells remaining rounded as on the separate segments TNfn1-5 and TNfbg. Thus the complete tenascin subunit can support adhesion when coated onto the plastic substratum as a mixture of smaller pieces.

Finally, we tested directly whether TNfnA-D or TNfn6-8 could inhibit adhesion to any defined adhesion substratum. Native FN, TNfn3 and TNfbg were separately coated on plastic and tested for cell adhesion in the presence of TNfnA-D or TNfn6-8, added with the cells as soluble molecules. TNfnA-D had no effect on adhesion to any substratum at concentrations up to 500 μg/ml. TNfn6-8 gave mixed results: in some experiments it inhibited cell adhesion to FN by 30-50% when added with cells at 20-500 μg/ml, but in other experiments under apparently identical conditions it gave no inhibition at all. Even in experiments showing inhibition, the concentration dependence was frequently erratic. We therefore could not demonstrate a reproducible inhibitory effect of TNfn6-8, but further work is clearly indicated in view of the substantial inhibitions reported by Chiquet et al. (1991) and Prieto et al. (1992).

We also tested whether the adhesion domains of tenascin might be revealed by breaking the hexabrachion structure into single arms. We treated TN with 2 mM DTT for 30 min before coating on plastic, conditions that we have found sufficient to reduce the disulfide bonds in the central nodule and convert the hexabrachion into single subunits (Erickson and Briscoe, 1993). Substrata of reduced TN coated on plastic at concentrations up to 100 μg/ml were completely negative for adhesion activity in this assay. If there is a structural feature that blocks cell adhesion it appears to be inherent to each arm of the hexabrachion.

Cell adhesion to TN and recombinant domains depends on the substratum (plastic vs nitrocellulose) and on the coating time

Because nitrocellulose is known to bind proteins tightly and in a conformation suitable for binding antibodies and other ligands, we compared cell adhesion to proteins coated either on plastic or nitrocellulose. Fig. 9 shows that the chemical nature of the supporting substratum has a dramatic effect on adhesion activity. When the proteins were coated on plastic at 4°C for 12 hours, TNfn3 (20 μg/ml) gave strong adhesion, TNfbg (50 μg/ml) a weaker adhesion, while native TN (100 μg/ml) gave a weaker but still significant adhesion. The very weak adhesion to TNfnA-D and TNfn6-8 was not seen in most experiments. Cells spread on TNfn3 and FN, but remained rounded on TNfbg. On nitrocellulose, TNfn3 again gave strong adhesion, but TNfbg had no activity. Most remarkable, native TN on nitrocellulose demonstrated strong adhesion activity. This cell adhesion activity was not due to contamination by fibronectin or other adhesive proteins, since it could be blocked by a polyclonal antiserum to TN. Interestingly, TNfn3 on nitrocellulose was less active than TNfn3 on plastic. Furthermore, cell spreading was greatly reduced when TNfn3 was coated on nitrocellulose, relative to the very pronounced spreading on TNfn3 on plastic. Cells adhering to native TN remained rounded on both plastic and nitrocellulose. Fibronectin, as a positive control, supported strong cell adhesion and spreading on both plastic and nitrocellulose.

Fig. 9.

Attachment of endothelial cells GM7373 on plastic (A) and nitrocellulose (B) coated with TN, TN fragments or FN. Each substratum was coated with native TN (100 μg/ml), TNfnA-D (50 μg/ml), TNfn3 (20 μg/ml), TNfn6-8 (50 μg/ml), TNfbg (50 μg/ml) or FN (50 μg/ml) for 12 hours at 4°C. GM7373 cells were harvested with trypsin-EDTA, washed, and allowed to attach on the substratum for 1 hour at 37°C. Attached cells were fixed, stained with toluidine blue, and read at 595 nm.

Fig. 9.

Attachment of endothelial cells GM7373 on plastic (A) and nitrocellulose (B) coated with TN, TN fragments or FN. Each substratum was coated with native TN (100 μg/ml), TNfnA-D (50 μg/ml), TNfn3 (20 μg/ml), TNfn6-8 (50 μg/ml), TNfbg (50 μg/ml) or FN (50 μg/ml) for 12 hours at 4°C. GM7373 cells were harvested with trypsin-EDTA, washed, and allowed to attach on the substratum for 1 hour at 37°C. Attached cells were fixed, stained with toluidine blue, and read at 595 nm.

The cell adhesion activity of native TN required a remarkably long incubation time for coating the substratum. Fig. 10 shows the adhesion to native TN, TNfn3 and FN coated on plastic and nitrocellulose at 4°C for different times. While the cell adhesion activity of FN and TNfn3 reached a maximum after 1-3 hours coating time, the activity of native TN increased much more slowly out to 24 hours, the last time tested. At all time points tested, TN gave higher adhesion on nitrocellulose than on plastic. In contrast, FN had the same activity on both substrata, while TNfn3 had lower adhesion on nitrocellulose and, as noted above, cells only partially spread on this substratum.

Fig. 10.

(A) Attachment of GM7373 cells on plastic and nitrocellulose coated with native TN, native FN and TNfn3, as a function of the time the proteins were incubated with the substratum. Proteins were coated at 20 μg/ml and 4°C. (B and C) Determination of the amount of substratum-bound TN (B) and TNfn3 (C), as a function of incubation time. Radiolabeled TN and TNfn3 (20 μg/ml each) were incubated with plastic and nitrocellulose for various time at 4°C and radioactivity of substratum-bound material was determined. (D) GRGDSP peptide inhibits endothelial cell adhesion to native TN. Substrata were coated with TN for 24 hours at 4°C. Control peptide GRGESP had no effect on adhesion at a concentration of 500 μg/ml.

Fig. 10.

(A) Attachment of GM7373 cells on plastic and nitrocellulose coated with native TN, native FN and TNfn3, as a function of the time the proteins were incubated with the substratum. Proteins were coated at 20 μg/ml and 4°C. (B and C) Determination of the amount of substratum-bound TN (B) and TNfn3 (C), as a function of incubation time. Radiolabeled TN and TNfn3 (20 μg/ml each) were incubated with plastic and nitrocellulose for various time at 4°C and radioactivity of substratum-bound material was determined. (D) GRGDSP peptide inhibits endothelial cell adhesion to native TN. Substrata were coated with TN for 24 hours at 4°C. Control peptide GRGESP had no effect on adhesion at a concentration of 500 μg/ml.

One possibility for the differential effects was that adhesion activity might reflect different amounts of protein bound to the substrata. We therefore compared the amount of TN and TNfn3 domain bound to plastic and nitrocellulose by using radiolabeled proteins. As expected, both TN and TNfn3 bound more abundantly to nitrocellulose than to plastic. Thus, at least for TNfn3, adhesion is not simply correlated with the amount of protein bound: adhesion is weaker on nitrocellulose even though more protein is bound. For native TN on nitrocellulose the time course of cell adhesion correlated reasonably well with that of protein binding. There was a 70% increase in both protein bound and adhesion at 24 hours compared to 6 hours. This correlation did not hold, however, for TN on plastic. Here protein binding was almost complete at 3-6 hours, increasing only about 20% from 6 to 24 hours. In contrast, cell adhesion doubled from 6 to 24 hours. These results suggest that the majority of TN molecules that bound to plastic in the first 3-6 hours of incubation are not active in cell adhesion, while a smaller fraction that bound over the next 18 hours are active.

We also tested whether the GRGDSP peptide would inhibit cell adhesion to native TN. The peptide GRGDSP completely inhibited adhesion of cells to TN coated on either plastic or nitrocellulose at a concentration of 20-50 μg/ml (Fig. 10D). The control peptide GRGESP had no effect on adhesion at concentrations up to 500 μg/ml. The GRGDSP peptide thus inhibits adhesion to native TN at low concentrations, similar to those effective on TNfn3 and TNfbg, and at least 10 times lower than the concentrations needed to inhibit adhesion to FN.

Our initial study of rat embryo skin fibroblasts (Aukhil et al., 1993), identified a single cell adhesion domain in TN, TNfbg. Prieto et al. (1992) observed adhesion of several cell types to their fusion proteins containing TNfn3, and they have also demonstrated adhesion of fibroblasts to our expression proteins containing TNfn3 (see note to Table 1). We conclude that their assay is more sensitive than ours in detecting the weak adhesion of fibroblasts to TNfn3.

We were surprised that fibroblasts did not adhere to either TNfn3 or FNfn10, because each of these domains contains the RGD sequence. We therefore expanded our study from fibroblasts to a variety of other cell types, and discovered that endothelial cells adhere strongly to both of these domains, as well as to larger segments that contain them. The vigorous adhesion of endothelial cells makes them an ideal candidate for identifying cell adhesion substrata. In the present study endothelial cells have been especially valuable in demonstrating the two cell adhesion domains of TN.

The first site, which mediates adhesion of fibroblasts (Aukhil et al., 1993) and all other cells tested, is in the terminal knob domain, TNfbg. This site is probably the one that Spring et al. (1989) attributed to the adjacent TNfn7- 8, and it has been demonstrated independently by Prieto et al. (1992). In this latter study, as in ours, cells remain rounded on TNfbg. Surprisingly, the mechanism of adhesion to TNfbg seems to vary with cell type. Fibroblasts adhere via a heparin sulfate proteoglycan (Aukhil et al., 1993), while the present study suggests that endothelial cells may adhere via an integrin. The inhibition of adhesion by RGD peptides is remarkable because TNfbg does not contain any RGD sequence, but this situation is not unique. The matrix Gla protein also contains no RGD sequence, but cell adhesion is strongly inhibited by 3 μg/ml of soluble RGD peptide (Loeser and Wallin, 1992).

The second cell adhesion site is TNfn3, which contains an RGD sequence in human and chick TN. Endothelial cells adhere strongly to and spread on TNfn3 and on TNfn3-5. All segments containing TNfn3 and having TNfn2 attached at the N terminus gave weaker adhesion and the cells remained rounded. The explanation for the reduced adhesion was suggested by the X-ray crystal structure (Leahy et al., 1992), which showed the RGD segment to be near the N terminus of TNfn3, where it can be partially blocked by TNfn2. Adhesion to TNfn3, and also to the single FN domain FNfn10, appears to be mediated by the αvβ3integrin, because it is blocked by an antibody to that integrin, requires divalent cations, and is exquisitely sensitive to soluble RGD peptides.

The activities of TNfn6-8 remain controversial. Two laboratories have reported anti-adhesion activity for these domains (Chiquet et al., 1991; Prieto et al., 1992), but in our experiments TNfn6-8 gave equivocal results. We sometimes observed an inhibition of cell adhesion, but in most experiments the effect was not reproduced. Prieto et al. (1992) also reported that TNfn7-8 would support cell adhesion if the cells were treated with trypsin before the assay. Our cells are routinely harvested with trypsin before the assay and we found no adhesion to TNfn6-8.

Why do endothelial cells adhere more strongly than fibroblasts to the RGD-containing domains? One possibility is that endothelial cells may have substantially more αvβ3integrin than fibroblasts. αvβ3and α5β1both contribute to adhesion of microvascular endothelial cells to intact FN (Cheng et al., 1991), but HT-1080 fibrosarcoma cells use only α5β1to adhere to FN and to expression proteins similar to our FNfn7-10 (Aota et al., 1991).

We do not understand why adhesion to TNfn3 is stronger than to FNfn10. Both of these single FN-III domains contain an RGD sequence on a tight turn between the F and G beta strands (Leahy et al., 1992; Main et al., 1992). If anything, we would have expected stronger adhesion to FNfn10, in which the RGD loop extends outward about 7 Å further than in TNfn3. The strong adhesion to TNfn3 might involve other patches on the surface of this domain, but we have not initiated tests that might reveal the mechanism.

What is the biological significance of endothelial cell adhesion to TNfn3 and TNfbg? Two observations suggest that adhesion to TNfn3 may not be biologically important. First, this adhesion is dramatically reduced in the native molecule or in any protein that has TNfn2 linked to TNfn3. One might postulate a specific proteolytic cleavage, or a bending of the hexabrachion arm, that could expose the stronger adhesion site, but there is no evidence for such processing. Second, the RGD sequence that is found in human and chick TN is replaced by RVD in mouse (Weller et al., 1991; Saga et al., 1991), RAD in pig (Nishi et al., 1991), and RGL in newt (Onda et al., 1991) TN. Both the cryptic location of the RGD in the intact TN molecule, and the species variation of the RGD sequence, suggest that this site may not be functional in cell adhesion.

Cell adhesion to TNfbg seems more likely to be biologically important. This site at the tip of each arm of the hexabrachion is ideally exposed for binding to cell surfaces, and indeed almost all cells tested bind to it (Prieto et al., 1992; Aukhil et al., 1993, and this paper). Although the cell adhesion to TNfbg is weaker than to FN or vitronectin, the large size and multivalent structure of the hexabrachion would make it an ideal bridge between cells. Alternatively, the physiological role of cells binding TNfbg might be something other than cell adhesion. The receptors for TNfbg might respond directly to the ligand binding by a signalling mechanism, or the binding might enhance interaction of TN with other receptors.

The experiments reported here may resolve the long controversy over the cell adhesion activity of native TN. Previous studies in our laboratory and several others reported no cell adhesion to TN-coated plastic substrata (Erickson and Taylor, 1987; Mackie et al., 1987; Lotz et al., 1989; Lightner and Erickson, 1990; Aukhil et al., 1990; Saginati et al., 1992), whereas other groups have reported a weak adhesion of cells with a rounded morphology (Friedlander et al., 1988; Bourdon and Ruoslahti, 1989; Chiquet-Ehrismann et al., 1988; Spring et al., 1989; Nörenberg et al., 1992; Prieto et al., 1992). Our present experiments suggest that the adhesion activity depends on how the substratum is prepared. If native TN is coated on plastic for 1-2 hours, the standard conditions for our assays over the years, it has no adhesion activity. We have now found two conditions that reveal a cell adhesion activity of TN: (1) coat the protein on plastic as separate domains or as a mixture of expression proteins, corresponding to tenascin subunits cut into pieces; or (2) coat the plastic with native TN for 1224 hours, instead of the 1-2 hours that is sufficient for most other adhesion proteins (coating on nitrocellulose produces a stronger adhesion than on plastic). The mechanism for exposing or concealing the adhesion site(s) is not clear, but it may involve the orientation of the molecules when they are coated under different conditions. For example, it may be important that the terminal knobs, which we believe are the active adhesion domains in native TN, are pointing up toward the cells rather than bound to the plastic.

The results of the study by Sriramarao et al. (1993) agree with most of our findings and complements our observations in important aspects. They observed adhesion of endothelial cells to native TN coated on plastic (note that they coated the plastic overnight, 12-14 hours) and identified two integrins that are involved. Both their results and ours show that αvβ3binds to the TN domain TNfn3. The second TN-binding integrin that Sriramarao et al. discovered, α2β1, bound to an unknown domain of TN. In our work we concluded that the TN domain TNfbg bound an unknown integrin. We suggest that these results complement each other, and α2β1may be the integrin that binds TNfbg. Moreover, the peptide and antibody inhibition studies suggest that α2β1integrin binding to TNfbg may be the primary mechanism of adhesion of endothelial cells to native TN. The peptide GRGDSP inhibited adhesion to both TNfbg and native TN (Figs 8, 10D; and Bourdon and Rouslahti, 1989), whereas the SRRGDMS peptide from TNfn3 only partially inhibited adhesion to native TN. Antibodies against α2β1blocked adhesion to native TN much more effectively than antibodies against αvβ3. As suggested above, the binding of αvβ3to TNfn3 may not be a biologically significant mechanism, but binding of α2β1to TNfbg probably plays a role in binding native TN to endothelial cells.

Finally, we must recognize that the activities observed in these cell culture assays are apparently not vital for normal animal development, since complete deletion of TN in a mouse produced no detectable phenotype (Saga et al., 1992). TN is apparently not an essential component of the endothelium, in spite of the fact that it is localized around many blood vessels and mediates adhesion of endothelial cells. It is premature, however, to conclude that TN has no role in blood vessel structure. It is possible that TN contributes in a non-vital but supportive capacity to angiogenesis, to maintain the structure of formed blood vessels, or to modulate the function of endothelial and smooth muscle cells. The roles of TN may be subtle, contributing to survival under conditions of stress, yet not producing a gross phenotype that would be obvious from casual observation of mice in a laboratory environment. Biochemical and cell culture experiments may provide clues as to where to look for subtle roles in living animals. The present work suggests that the vasculature in the tenascin knockout mice should be examined closely for defects, perhaps under conditions of stress.

This work was supported by National Institutes of Health grants R37-CA-47056 to H.P.E. and R01-DE-07801 to I.A. We thank Dr Richard Auerbach, University of Wisconsin, for supplying several lines of endothelial cells.

Aota
,
S.
,
Nagai
,
T.
and
Yamada
,
K. M.
(
1991
).
Characterization of regions of fibronectin besides the arginine-glycine-aspartic acid sequence required for adhesive function of the cell-binding domain using site-directed mutagenesis
.
J. Biol. Chem
.
266
,
15938
15943
.
Aukhil
,
I.
,
Joshi
,
P.
,
Yan
,
Y. Z.
and
Erickson
,
H. P.
(
1993
).
Cell- and heparin-binding domains of the hexabrachion arm identified by tenascin expression proteins
.
J. Biol. Chem
.
268
,
2542
2553
.
Aukhil
,
I.
,
Slemp
,
C. A
,
Lightner
,
V. A.
,
Nishimura
,
K.
,
Briscoe
,
G.
and
Erickson
,
H. P.
(
1990
).
Purification of hexabrachion (tenascin) from cell culture conditioned medium, and separation from a cell adhesion factor
.
Matrix
10
,
98
111
.
Bourdon
,
M. A.
and
Ruoslahti
,
E.
(
1989
).
Tenascin mediates cell attachment through an RGD-dependent receptor
.
J. Cell Biol
.
108
,
11491155
.
Cheng
,
Y.-F.
,
Clyman
,
R. I.
,
Enenstein
,
J.
,
Waleh
,
N.
,
Pytela
,
R.
and
Kramer
,
R. H.
(
1991
).
The integrin complex αv β3 participates in the adhesion of microvascular endothelial cells to fibronectin
.
Exp. Cell Res
.
194
,
69
77
.
Chiquet
,
M.
,
Vrucinic-Filipi
,
N.
,
Schenk
,
S.
,
Beck
,
K.
and
Chiquet-Ehrismann
,
R.
(
1991
).
Isolation of chick tenascin variants and fragments. A C-terminal heparin-binding fragment produced by cleavage of the extra domain from the largest subunit splicing variant
.
Eur. J. Biochem
.
199
,
379
388
.
Chiquet-Ehrismann
,
R.
,
Kalla
,
P.
,
Pearson
,
C. A.
,
Beck
,
K.
and
Chiquet
,
M.
(
1988
).
Tenascin interferes with fibronectin action
.
Cell
53
,
383
390
.
Erickson
,
H. P.
and
Bourdon
,
M. A.
(
1989
).
Tenascin: an extracellular matrix protein prominent in specialized embryonic tissues and tumors
.
Annu. Rev. Cell Biol
.
5
,
71
92
.
Erickson
,
H. P.
and
Briscoe
,
G.
(
1993
).
Purification of tenascin, laminin and fibronectin from tissue culture conditioned medium
.
In Extracellular Matrix Molecules: a Practical Approach
(ed.
M. A.
Haralson
and
J. R.
Hassell
).
Oxford University Press (in press
).
Erickson
,
H. P.
and
Taylor
,
H. C.
(
1987
).
Hexabrachion proteins in embryonic chicken tissues and human tumors
.
J. Cell Biol
.
105
,
13871394
.
Friedlander
,
D. R.
,
Hoffman
,
S.
and
Edelman
,
G. M.
(
1988
).
Functional mapping of cytotactin: Proteolytic fragments active in cell-substratum adhesion
.
J. Cell Biol
.
107
,
2329
2340
.
Greenwood
,
F. C.
,
Hunter
,
W. M.
and
Glover
,
J. S
(
1963
).
The preparation of 131 I-labelled human growth hormone of high specific radioactivity
.
Biochem. J
.
89
,
114
123
.
Grinspan
,
J. B.
,
Mueller
,
S. N.
and
Levine
,
E. M.
(
1983
).
Bovine endothelial cells transformed in vitro by benzo(a)pyrene
.
J. Cell. Physiol
.
114
,
328
338
.
Hynes
,
R. O.
(
1992
).
Integrins: Versatility, modulation, and signaling in cell adhesion
.
Cell
69
,
11
25
.
Kimizuka
,
F.
,
Ohdate
,
Y.
,
Kawase
,
Y.
,
Shimojo
,
T.
,
Taguchi
,
Y.
,
Hashino
,
K.
,
Goto
,
S.
,
Hashi
,
H.
,
Kato
,
I.
,
Sekiguchi
,
K.
and
Titani
,
K.
(
1991
).
Role of type III homology repeats in cell adhesive function within the cell-binding domain of fibronectin
.
J. Biol. Chem
.
266
,
3045
3051
.
Leahy
,
D. J.
,
Hendrickson
,
W. A.
,
Aukhil
,
I.
and
Erickson
,
H. P.
(
1992
).
Structure of a fibronectin type III domain from tenascin phased by MAD analysis of the selenomethionyl protein
.
Science
258
,
987
991
.
Lightner
,
V. A.
and
Erickson
,
H. P.
(
1990
).
Binding of hexabrachion (tenascin) to the extracellular matrix and substratum and its effect on cell adhesion
.
J. Cell Sci
.
95
,
263
277
.
Loeser
,
R. F.
and
Wallin
,
R.
(
1992
).
Cell adhesion to matrix Gla protein and its inhibition by an Arg-Gly-Asp-containing peptide
.
J. Biol. Chem
.
267
,
9459
9462
.
Lotz
,
M. M
,
Burdsal
,
C. A.
,
Erickson
,
H. P.
and
McClay
,
D. R.
(
1989
).
Cell adhesion to fibronectin and tenascin: quantitative measurements of initial binding and subsequent strengthening response
.
J. Cell Biol
.
109
,
1795
1805
.
Mackie
,
E. J.
,
Thesleff
,
I.
and
Chiquet-Ehrismann
,
R.
(
1987
).
Tenascin is associated with chondrogenic and osteogenic differentiation in vivo and promotes chondrogenesis in vitro
.
J. Cell Biol
.
105
,
2569
2579
.
Maier
,
J. A. M.
,
Rusnati
,
M.
,
Ragnotti
,
G.
and
Presta
,
M.
(
1990
).
Characterization of a Mr 20,000 basic fibroblast growth factor-like protein secreted by normal and transformed fetal bovine aortic endothelial cells
.
Exp. Cell Res
.
186
,
354
361
.
Main
,
A. L.
,
Harvey
,
T. S.
,
Baron
,
M.
,
Boyd
,
J.
and
Campbell
,
I. D.
(
1992
).
The three-dimensional structure of the tenth type III module of fibronectin: An insight into RGD-mediated interactions
.
Cell
71
,
671678
.
Massia
,
S. P.
and
Hubbell
,
J. A.
(
1991
).
An RGD spacing of 440 nm is sufficient for integrin αv β3 -mediated fibroblast spreading and 140 nm for focal contact and stress fiber formation
.
J. Cell Biol
.
114
,
1089
1100
.
Murphy-Ullrich
,
J. E.
,
Lightner
,
V. A.
,
Aukhil
,
I.
,
Yan
,
Y. Z.
,
Erickson
,
H. P.
and
Höök
,
M.
(
1991
).
Focal adhesion integrity is downregulated by the alternatively spliced domain of human tenascin
.
J. Cell Biol
.
115
,
1127
1136
.
Nishi
,
T.
,
Weinstein
,
J.
,
Gillespie
,
W. M.
and
Paulson
,
J. C.
(
1991
).
Complete primary structure of porcine tenascin. Detection of tenascin transcripts in adult submaxillary glands
.
Eur. J. Biochem
.
202
,
643
648
.
Nörenberg
,
U.
,
Wille
,
H.
,
Wolff
,
J. M.
,
Frank
,
R.
and
Rathjen
,
F. G.
(
1992
).
The chicken neural extracellular matrix molecule restrictin: Similarity with EGF-, fibronectin type III-, and fibrinogen-like motifs
.
Neuron
8
,
849
863
.
Onda
,
H.
,
Poulin
,
M. L.
,
Tassava
,
R. A.
and
Chiu
,
I.-M.
(
1991
).
Characterization of a newt tenascin cDNA and localization of tenascin mRNA during newt limb regeneration by in situ hybridization
.
Dev. Biol
.
148
,
219
232
.
Pierschbacher
,
M. D.
and
Ruoslahti
,
E.
(
1984
).
Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule
.
Nature
309
,
30
33
.
Pierschbacher
,
M. D.
and
Ruoslahti
,
E.
(
1987
).
Influence of stereochemistry of the sequence Arg-Gly-Asp-Xaa on binding specificity in cell adhesion
.
J. Biol. Chem
.
262
,
17294
17298
.
Prieto
,
A. L.
,
Andersson-Fisone
,
C.
and
Crossin
,
K. L.
(
1992
).
Characterization of multiple adhesive and counteradhesive domains in the extracellular matrix protein cytotactin
.
J. Cell Biol
.
119
,
663
678
.
Saga
,
Y.
,
Tsukamoto
,
T.
,
Jing
,
N.
,
Kusakabe
,
M.
and
Sakakura
,
T.
(
1991
).
Murine tenascin: cDNA cloning, structure and temporal expression of isoforms
.
Gene
104
,
177
185
.
Saga
,
Y.
,
Yagi
,
T.
,
Ikawa
,
Y.
,
Sakakura
,
T.
and
Aizawa
,
S.
(
1992
).
Mice develop normally without tenascin
.
Genes Dev
.
6
,
1821
1831
.
Saginati
,
M.
,
Siri
,
A.
,
Balza
,
E.
,
Ponassi
,
M.
and
Zardi
,
L.
(
1992
).
A simple procedure for tenascin purification
.
Eur. J. Biochem
.
205
,
545
549
.
Spring
,
J.
,
Beck
,
K.
and
Chiquet-Ehrismann
,
R.
(
1989
).
Two contrary functions of tenascin: dissection of the active site by recombinant tenascin fragments
.
Cell
59
,
325
334
.
Sriramarao
,
P.
,
Mendler
,
M.
and
Bourdon
,
M. A.
(
1993
).
Endothelial cell attachment and spreading on human tenascin is mediated by alpha2-beta1 and alphaV-beta3 integrins
.
J. Cell Sci
.
Weller
,
A.
,
Beck
,
S.
and
Ekblom
,
P.
(
1991
).
Amino acid sequence of mouse tenascin and differential expression of two tenascin isoforms during embryogenesis
.
J. Cell Biol
.
112
,
355
362
.

We have recently developed three polyclonal antibodies to separate recombinant proteins that allow us to probe the domains that promote adhesion to the native TN substratum. Antibodies to TNfn1-5 or TNfnA-D, applied to the TN substratum before the cells, inhibited adhesion of endothelial cells only slightly, while an antibody to TNfn6-8 plus TNfbg (the two proteins were combined for this immunization) inhibited adhesion 80%. Thus TNfbg appears to be the major cell adhesion site in substrata of native TN.